These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3781190)

  • 1. Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis.
    Czaja AJ; Beaver SJ; Shiels MT
    Gastroenterology; 1987 Jan; 92(1):215-9. PubMed ID: 3781190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis in postmenopausal women: a retrospective analysis.
    Wang KK; Czaja AJ
    Gastroenterology; 1989 Nov; 97(5):1288-93. PubMed ID: 2792661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and prognosis of histologic cirrhosis in corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis.
    Davis GL; Czaja AJ; Ludwig J
    Gastroenterology; 1984 Dec; 87(6):1222-7. PubMed ID: 6489694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis.
    Czaja AJ; Davis GL; Ludwig J; Taswell HF
    Hepatology; 1984; 4(4):622-7. PubMed ID: 6745850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis.
    Czaja AJ
    Hepatology; 1990 Jun; 11(6):1044-9. PubMed ID: 2365282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis.
    Czaja AJ; Menon KV; Carpenter HA
    Hepatology; 2002 Apr; 35(4):890-7. PubMed ID: 11915036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission.
    Czaja AJ; Ammon HV; Summerskill WH
    Gastroenterology; 1980 Mar; 78(3):518-23. PubMed ID: 7351290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and prognostic implications of HLA B8 in corticosteroid-treated severe autoimmune chronic active hepatitis.
    Czaja AJ; Rakela J; Hay JE; Moore SB
    Gastroenterology; 1990 Jun; 98(6):1587-93. PubMed ID: 2338197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis.
    Czaja AJ; Hay JE; Rakela J
    Mayo Clin Proc; 1990 Jan; 65(1):23-30. PubMed ID: 2296210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune features as determinants of prognosis in steroid-treated chronic active hepatitis of uncertain etiology.
    Czaja AJ; Davis GL; Ludwig J; Baggenstoss AH; Taswell HF
    Gastroenterology; 1983 Sep; 85(3):713-7. PubMed ID: 6192038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral pulse prednisone therapy in the treatment of HBsAg negative chronic active hepatitis.
    Chase WF; Winn RE; Mayes GR
    Gastroenterology; 1982 Dec; 83(6):1292-6. PubMed ID: 7129032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid-treated chronic active hepatitis in remission: uncertain prognosis of chronic persistent hepatitis.
    Czaja AJ; Ludwig J; Baggenstoss AH; Wolf A
    N Engl J Med; 1981 Jan; 304(1):5-9. PubMed ID: 7432437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis.
    Sanchez-Urdazpal L; Czaja AJ; van Hoek B; Krom RA; Wiesner RH
    Hepatology; 1992 Feb; 15(2):215-21. PubMed ID: 1735524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and significance of serum alpha-fetoprotein elevation in severe hepatitis B surface antigen-negative chronic active hepatitis.
    Czaja AJ; Beaver SJ; Wood JR; Klee GG; Go VL
    Gastroenterology; 1987 Oct; 93(4):687-92. PubMed ID: 2442060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of chronic type B hepatitis in patients who acquire hepatitis B virus infection in childhood.
    Bortolotti F; Cadrobbi P; Crivellaro C; Guido M; Rugge M; Noventa F; Calzia R; Realdi G
    Gastroenterology; 1990 Sep; 99(3):805-10. PubMed ID: 2379783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of serum hepatitis B virus deoxyribonucleic acid in hepatitis B surface antigen-positive patients with chronic persistent hepatitis treated with prednisone.
    Tong MJ; Liu S; Co RL
    Gastroenterology; 1987 Apr; 92(4):862-6. PubMed ID: 3556993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis.
    Czaja AJ; Taswell HF; Rakela J; Schimek CM
    Mayo Clin Proc; 1991 Jun; 66(6):572-82. PubMed ID: 1646353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
    Tanno H; Fay O; Roldán L; Vorovioff J
    Acta Gastroenterol Latinoam; 1982; 12(4):323-32. PubMed ID: 7185230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus deoxyribonucleic acid in serum during hepatitis B e antigen clearance in corticosteroid-treated severe chronic active hepatitis B.
    Wood JR; Czaja AJ; Taswell HF; Ludwig J; Rakela J; Chase R
    Gastroenterology; 1987 Dec; 93(6):1225-30. PubMed ID: 3678739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B.
    Papatheodoridis GV; Manolakopoulos S; Su TH; Siakavellas S; Liu CJ; Kourikou A; Yang HC; Kao JH
    Hepatology; 2018 Aug; 68(2):415-424. PubMed ID: 28859219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.